Video

INSPIRE and IMvigor011 Trials

Jason Starr, DO, discusses the INSPIRE and IMvigor011 studies that focused on the use of ctDNA in MRD.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Dr Christina Poh
Related Content
Lungs | Image: Inspira Health
August 9th 2025

Zongertinib Granted Accelerated Approval in Nonsquamous NSCLC for HER2 TKD-Activating Mutations

Mary Caffrey Brooke McCormick
managed care cast logo
August 9th 2025

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

Brooke McCormick Stephen Lott, PharmD, MS Jonathan Gabison, MD, DABOM
Lung cancer | Image credit: Sebastian Kaulitzki - stock.adobe.com
August 9th 2025

Immune Checkpoint Inhibitors More Effective vs Bevacizumab in Nonsquamous NSCLC

Julia Bonavitacola
managed care cast logo
August 9th 2025

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick
Depiction of inflammation | Image Credit: picture-waterfall - stock.adobe.com
August 9th 2025

Higher Oxidative Balance Score Linked to Lower Systemic Inflammation, Study Finds

Brooke McCormick
AJMC
August 9th 2025

US Health Care Disparities in Immunology Biologics Access: A Systematic Review

Grace C. Wright, MD, PhD Ginette A. Okoye, MD Adam C. Ehrlich, MD, MPH D. J. Lorimier, PharmD, MS Shahnaz Khan, MPH Alisha Krumbach, PharmD Catherine Copley-Merriman, MS, MBA Kateryna Onishchenko, PhD Osayi Ovbiosa, PhD Manish Mittal, PhD

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo